⚖ SoapBox law
CasesDocketsStatutesRegulationsJudgesLawyersFile a complaintOversightDataLibrary

Cases

Search U.S. court opinions (CourtListener / Free Law Project), or resolve a reporter citation to its case via the Caselaw Access Project. Facts only — name, court, date, status, citation count. Never a holding-summary.

4 opinions for “Arena Pharmaceuticals Inc. v. Lupin Ltd.”

District Court, D. Delaware · 2013-02-11 · Published · cited 1× · 923 F. Supp. 2d 602; 2013 WL 509152; 2013 U.S. Dist. LEXIS 18176
*608 MEMORANDUM OPINION BURKE, United States Magistrate Judge. INTRODUCTION Plaintiff, Bristol-Myers Squibb Company (“BMS”), markets a medication under the trade name Baraclude® for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication, and either evidence of p
Court of Appeals for the Federal Circuit · 2012-09-04 · Published · cited 45× · 694 F.3d 1344; 104 U.S.P.Q. 2d (BNA) 1641; 2012 U.S. App. LEXIS 18592; 2012 WL 3797966
NEWMAN, Circuit Judge, concurring in part, dissenting in part. I agree that inequitable conduct has not been shown. However, the court errs in three major areas, misconstruing established law. First, the court creates a new “written description” requirement for limitations in claims, a requirement with inn portant consequences for patent content and; prosecution, and that will
Court of Appeals for the Federal Circuit · 2014-12-05 · Published · cited 354× · 773 F.3d 1245; 113 U.S.P.Q. 2d (BNA) 1097; 2014 U.S. App. LEXIS 22902; 2014 WL 6845152
Opinion for the court filed by Circuit Judge CHEN. Dissenting opinion filed by Circuit Judge MAYER. CHEN, Circuit Judge. Defendants-Appellants National Leisure Group, Inc. and World Travel Holdings, Inc. (collectively, NLG) appeal from a final judgment of the United States District Court for the Eastern District of Texas entered in favor of Plaintiff-Appellee DDR Holdings, LLC (DDR).
District Court, D. Rhode Island · 2017-08-08 · Published · cited 9× · 261 F. Supp. 3d 307
*314OPINION AND ORDER William E. Smith, Chief Judge The plaintiffs in this multidistrict litigation (“MDL”) seek damages from the defendant-pharmaceutical companies for an allegedly anti-competitive scheme relating to Loestrin 24 FE (“Loestrin 24”), an oral contraceptive comprising 24 norethindrone acetate/ethinyl estradiol (1 mg/20 meg) tablets and f